Precision therapy without the beam

Innovating Localized Radiation Therapy

Pancreatic cancer survivor discusses CivaSheet Implant

CivaTech Oncology® designs innovative products that bring meaningful improvements to low dose rate brachytherapy. The CivaString® and CivaSheet® can substantially reduce procedure time, provide homogeneous dose distribution and minimize trauma. Customizable CivaTech products insure that radiation oncologists can deliver individualized, targeted therapy to treat cancer.

CivaSheet

CivaSheet is the only FDA cleared, unidirectional, planar brachytherapy source. It is flexible, bioabsorbable and features CivaTech’s proprietary polymer encapsulated source technology.

CivaString

CivaString is a unique linear, polymer-encapsulated, low-dose-rate (LDR) brachytherapy source used to treat localized, solid tumors.

CivaDerm

CivaDerm™ is a temporary radiation therapy product designed for intraoperative or surface radiation to treat skin cancer and other lesions.

Polymer source technology is here!

The novel CivaString, CivaSheet and CivaDerm seamlessly integrate into current clinical workflows, beginning with your usual imaging modalities, through treatment planning, and ending with post-implant dosimetry.

Learn about CivaString the non-metal alternative to seeds

Learn More

For Professionals

CivaTech’s novel CivaString and CivaSheet seamlessly integrate into current clinical workflows, beginning with your usual imaging modalities, through treatment planning, and ending with post-implant dosimetry.

Abstracts and Presentations

For Patients

Patients being treated for prostate and other cancers may benefit from the implantation of CivaTech’s unique low dose rate brachytherapy sources, available as CivaString and CivaSheet.

Learn More

Interested in using our products?

Learn More

“Dr. Prestidge indicated he got 99.9% coverage of the prostate using 12 needles. I perhaps was in recovery for less than an hour. I felt very very comfortable; I had virtually no discomfort for a good period of time.”

CivaString Patient

“I got the CivaString and the results have been excellent! My first PSA after implant was .35 and my second PSA was .20. I am scheduled for my third blood test in July. Your product seems to have done the trick. I’m 75 and back playing racquetball”

CivaString Patient

Notable Achievements

CivaString and CivaSheet are the only implantable radiation therapy devices encapsulated with polymers and approved by the Nuclear Regulatory Commission as a sealed source.

CivaSheet is the only bioabsorbable and directional radiation therapy device approved by the FDA.
Manufacturing meets FDA guidelines for medical devices and highest international standards of ISO 13485 for production in a clean room environment.
The Company has two licenses with the NRC Agreement State of North Carolina. One license allows CivaTech to conduct broad research and the other allows for the manufacture and distribution of products containing radioactive material.
The CivaSheet has been supported by the NIH/NCI
CivaString and CivaSheet have both been FDA cleared to treat cancers of any solid tumor such as Prostate, Pancreas, Sarcoma, Head and Neck, Gyn, Colorectal, Breast, Brain, etc.

Our History

CivaTech Oncology Inc., a corporation located in Research Triangle Park, North Carolina, was founded in 2006. CivaTech Oncology offers cancer patients radiation therapy treatment options that minimize distress and inconvenience, maximize quality of life and improve life expectancy. The Company developed and is commercializing innovative polymer-based low-dose rate (LDR) brachytherapy devices, pioneering a new standard of care in treatment of various stages of cancer.